Sodium Gluconate, Gluconic Acid, and Derivative Products From China; Determinations

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

March 20, 2024

Issuing agencies

International Trade Commission

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 55 (Wednesday, March 20, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 55 (Wednesday, March 20, 2024)]
[Notices]
[Page 19876]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-05919]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation Nos. 701-TA-590 and 731-TA-1397 (Review)]


Sodium Gluconate, Gluconic Acid, and Derivative Products From 
China; Determinations

    On the basis of the record \1\ developed in the subject five-year 
reviews, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that revocation of the antidumping and countervailing duty 
orders on sodium gluconate, gluconic acid, and derivative products from 
China would be likely to lead to continuation or recurrence of material 
injury to an industry in the United States within a reasonably 
foreseeable time.
---------------------------------------------------------------------------

    \1\ The record is defined in Sec.  207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------

Background

    The Commission instituted these reviews on October 2, 2023 (88 FR 
67807) and determined on January 5, 2024 that it would conduct 
expedited reviews (89 FR 3426, January 18, 2024).
    The Commission made these determinations pursuant to section 751(c) 
of the Act (19 U.S.C. 1675(c)). It completed and filed its 
determinations in these reviews on March 15, 2024. The views of the 
Commission are contained in USITC Publication 5498 (March 2024), 
entitled Sodium Gluconate, Gluconic Acid, and Derivative Products from 
China: Investigation Nos. 701-TA-590 and 731-TA-1397 (Review).

    By order of the Commission.

    Issued: March 15, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024-05919 Filed 3-19-24; 8:45 am]
BILLING CODE 7020-02-P


</pre></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on March 20, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.